Toma Oganezova

Toma Oganezova is a medical oncologist, Editor-in-Chief of OncoDaily IO, and Junior Researcher at the Immune Oncology Research Institute (IMMONC). She is dedicated to advancing cancer immunotherapy through scientific communication, clinical research, and medical education.

Toma Oganezova is a medical oncologist with a strong interest in immuno-oncology, translational research, and evidence-based cancer care. As Editor-in-Chief of OncoDaily IO, she leads editorial strategy and develops educational content highlighting the latest advances in cancer immunotherapy, biomarkers, clinical trials, and precision oncology.

She is also a Junior Researcher at the Immune Oncology Research Institute (IMMONC), where she contributes to immuno-oncology research and authors scientific articles exploring emerging therapies, novel biomarkers, and translational discoveries in cancer immunotherapy.

Her primary areas of interest include immune checkpoint inhibitors, cancer vaccines, tumor microenvironment biology, mechanisms of immune resistance, predictive biomarkers, and innovative combination immunotherapies. She closely follows major international oncology conferences and practice-changing clinical trials, translating complex scientific evidence into clear, evidence-based educational content for clinicians and researchers.

Through collaborations with oncologists, scientists, and researchers worldwide, Toma strives to bridge the gap between research and clinical practice by making cutting-edge oncology research accessible to the global medical community. She believes that continuous learning, scientific collaboration, and high-quality medical education are essential to advancing cancer care and improving patient outcomes.